Evidence map›Paper›PMID 28196110›Full record

ArticlePloS one2017

Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians.

Geffen Kleinstern, Rania Abu Seir, Riki Perlman, Areej Khatib, Ziad Abdeen, Husein Elyan, Ronit Nirel, Gail Amir, Asad Ramlawi, Fouad Sabatin and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 4 countries.

Geffen KleinsternSchool of Public Health, Hadassah-Hebrew University Medical Organization, Jerusalem, Israel.
Rania Abu SeirDept of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Riki PerlmanDept of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Areej KhatibCancer Care Center, Augusta Victoria Hospital, East Jerusalem.
Ziad AbdeenSchool Faculty of Medicine, Dept of Community Medicine, Al Quds University, Abu Deis, West Bank.
Husein ElyanBeit Jalla Hospital, West Bank, PA.
Ronit NirelDepartment of Statistics, Hebrew University, Jerusalem, Israel.
Gail AmirDept of Pathology, Hadassah Medical Center, Jerusalem, Israel.
Asad RamlawiDepartment of Primary Health Care, Ministry of Health, Ramallah, Palestine.
Fouad SabatinCancer Care Center, Augusta Victoria Hospital, East Jerusalem.
Paolo BoffettaTisch Cancer Institute and Institute for Translational Epidemiology, Mount Sinai School of Medicine, New York, New York, United States of America.
Eldad J DannRambam Medical Center and Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Meirav KedmiChaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Israel.
Martin EllisMeir Medical Center, Kfar Saba, Israel.
Arnon NaglerChaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Israel.
Dina Ben YehudaDept of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Ora PaltielSchool of Public Health, Hadassah-Hebrew University Medical Organization, Jerusalem, Israel.
Hadassah Medical Center · ILAl-Quds University · PSAugusta Victoria Hospital · ILHebrew University of Jerusalem · ILIcahn School of Medicine at Mount Sinai · USLa Jolla Pharmaceutical (United States) · USMeir Medical Center · ILPrimary Health Care · QASheba Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRisk factors for B-cell non-Hodgkin lymphoma (B-NHL) have not been assessed among Palestinian Arabs (PA) and Israeli Jews (IJ).

methodsIn a case-control study we investigated self-reported medical and lifestyle exposures, reporting odds ratios (ORs) and 95% confidence intervals [CIs], by ethnicity, for overall B-NHL and subtypes.

resultsWe recruited 823 cases and 808 healthy controls. Among 307 PA/516 IJ B-NHL cases (mean age at diagnosis = 51 [±17] versus 60 [±15] years, respectively) subtype distributions differed, with diffuse large B-cell lymphoma (DLBCL) being prominent among PA (71%) compared to IJ (41%); follicular lymphoma (FL), was observed in 14% versus 28%, and marginal zone lymphoma, in 2% versus 14%, respectively. Overall B-NHL in both populations was associated with recreational sun exposure OR = 1.43 [CI:1.07-1.91], black hair-dye use OR = 1.70 [CI:1.00-2.87], hospitalization for infection OR = 1.68 [CI:1.34-2.11], and first-degree relative with hematopoietic cancer, OR = 1.69 [CI:1.16-2.48]. An inverse association was noted with alcohol use, OR = 0.46 [CI:0.34-0.62]. Subtype-specific exposures included smoking (FL, OR = 1.46 [CI:1.01-2.11]) and >monthly indoor pesticide use (DLBCL, OR = 2.01 [CI:1.35-3.00]). Associations observed for overall B-NHL in PA only included: gardening OR = 1.93 [CI:1.39-2.70]; history of herpes, mononucleosis, rubella, blood transfusion (OR>2.5, P<0.01 for all); while for IJ risk factors included growing fruits and vegetables, OR = 1.87 [CI:1.11-3.15]; and self-reported autoimmune diseases, OR = 1.99 [CI:1.34-2.95].

conclusionsIn these geographically proximate populations we found some unique risk factors for B-NHL. Heterogeneity in the observed associations by ethnicity could reflect differences in lifestyle, medical systems, and reporting patterns, while variations by histology infer specific etiologic factors for lymphoma subtypes.

Indexed as

Life StyleAdultAgedArabsCase-Control StudiesFamily HealthHair DyesHumansIsraelLymphoma, B-CellLymphoma, Large B-Cell, DiffuseMiddle AgedOdds RatioRisk FactorsSunlightHair Dyes

Identifiers

PMID28196110
PMCPMC5308607
OpenAlexW2588272821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.